StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2025Score 0/30
$0.38−0.00 (-0.13%)

Close on Nov 13, 2026Market cap $4.07MP/E –Yield –

Gelteq ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -A$4.27M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Jun 30, 2025-A$4.27M–
FY2024Jun 30, 2024-A$1.73M–
FY2023Jun 30, 2023-A$1.88M–

More Gelteq figures

See a number that looks wrong?